home / stock / oncy / oncy quote
Last: | $0.99 |
---|---|
Change Percent: | 0.52% |
Open: | $0.99 |
Close: | $0.99 |
High: | $1.01 |
Low: | $0.99 |
Volume: | 180,693 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.99 | $0.99 | $0.99 | $1.01 | $0.99 | 180,693 | 07-02-2024 |
$0.9952 | $1 | $0.9952 | $1.02 | $0.99 | 155,454 | 07-01-2024 |
$0.99 | $1 | $0.99 | $1.0299 | $0.99 | 315,056 | 06-28-2024 |
$1.01 | $1.02 | $1.01 | $1.0475 | $1.01 | 167,884 | 06-27-2024 |
$1.04 | $1 | $1.04 | $1.05 | $0.9999 | 188,701 | 06-26-2024 |
$1.01 | $1.01 | $1.01 | $1.01 | $1 | 58,750 | 06-25-2024 |
$1.01 | $1 | $1.01 | $1.01 | $0.99 | 87,517 | 06-24-2024 |
$1.01 | $1 | $1.01 | $1.01 | $0.9999 | 109,143 | 06-21-2024 |
$0.9956 | $1.04 | $0.9956 | $1.04 | $0.98 | 268,041 | 06-20-2024 |
$1.02 | $1 | $1.02 | $1.04 | $0.99 | 344,338 | 06-19-2024 |
$1.02 | $1 | $1.02 | $1.04 | $0.99 | 344,338 | 06-18-2024 |
$1.01 | $1.01 | $1.01 | $1.04 | $0.9932 | 234,201 | 06-17-2024 |
$1.02 | $1.03 | $1.02 | $1.0491 | $1 | 325,140 | 06-14-2024 |
$1.03 | $1.03 | $1.03 | $1.0499 | $1.01 | 99,906 | 06-13-2024 |
$1.03 | $1.05 | $1.03 | $1.06 | $1 | 310,955 | 06-12-2024 |
$1.04 | $1.04 | $1.04 | $1.04 | $1 | 276,213 | 06-11-2024 |
$1.02 | $1.03 | $1.02 | $1.0517 | $1.02 | 193,821 | 06-10-2024 |
$1.05 | $1.08 | $1.05 | $1.08 | $1.04 | 154,999 | 06-07-2024 |
$1.06 | $1.06 | $1.06 | $1.09 | $1.05 | 154,704 | 06-06-2024 |
$1.07 | $1.05 | $1.07 | $1.0999 | $1.05 | 138,272 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONCY Stock Symbol:
NASDAQ Market:
Oncolytics Biotech Inc. Website:
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Canada NewsWire Clear path forward on key elements of the planned potential registration-enabling trial in HR+/HER2- metastatic breast cancer On track to report ove...
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Canada NewsWire Wayne Pisano , Chair of Oncolytics' Board of Directors, to serve as interim CEO Overall Survival data from BRACELET-1 breast ca...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...